Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels

Nishi Srivastava, Rahul K. Kollipara, Dinesh K. Singh, Jessica Sudderth, Zeping Hu, Hien Nguyen, Shan Wang, Caroline G. Humphries, Ryan Carstens, Kenneth E. Huffman, Ralph J. Deberardinis, Ralf Kittler

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The nuclear receptor peroxisome-proliferation-activated receptor gamma (PPARγ), a transcriptional master regulator of glucose and lipid metabolism, inhibits the growth of several common cancers, including lung cancer. In this study, we show that the mechanism by which activation of PPARγ inhibits proliferation of lung cancer cells is based on metabolic changes. We found that treatment with the PPARγ agonist pioglitazone triggers a metabolic switch that inhibits pyruvate oxidation and reduces glutathione levels. These PPARγ-induced metabolic changes result in a marked increase of reactive oxygen species (ROS) levels that lead to rapid hypophosphorylation of retinoblastoma protein (RB) and cell-cycle arrest. The antiproliferative effect of PPARγ activation can be prevented by suppressing pyruvate dehydrogenase kinase 4 (PDK4) or β-oxidation of fatty acids in vitro and in vivo. Our proposed mechanism also suggests that metabolic changes can rapidly and directly inhibit cell-cycle progression of cancer cells by altering ROS levels.

Original languageEnglish (US)
Pages (from-to)650-661
Number of pages12
JournalCell Metabolism
Volume20
Issue number4
DOIs
StatePublished - Oct 7 2014

Fingerprint

Peroxisomes
Reactive Oxygen Species
Cell Proliferation
Lung Neoplasms
pioglitazone
Neoplasms
Retinoblastoma Protein
Cytoplasmic and Nuclear Receptors
Cell Cycle Checkpoints
Pyruvic Acid
Lipid Metabolism
Glutathione
Cell Cycle
Fatty Acids
Glucose
Growth

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels. / Srivastava, Nishi; Kollipara, Rahul K.; Singh, Dinesh K.; Sudderth, Jessica; Hu, Zeping; Nguyen, Hien; Wang, Shan; Humphries, Caroline G.; Carstens, Ryan; Huffman, Kenneth E.; Deberardinis, Ralph J.; Kittler, Ralf.

In: Cell Metabolism, Vol. 20, No. 4, 07.10.2014, p. 650-661.

Research output: Contribution to journalArticle

Srivastava, Nishi ; Kollipara, Rahul K. ; Singh, Dinesh K. ; Sudderth, Jessica ; Hu, Zeping ; Nguyen, Hien ; Wang, Shan ; Humphries, Caroline G. ; Carstens, Ryan ; Huffman, Kenneth E. ; Deberardinis, Ralph J. ; Kittler, Ralf. / Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels. In: Cell Metabolism. 2014 ; Vol. 20, No. 4. pp. 650-661.
@article{50991430b53e4c48a3fbcd47f0146764,
title = "Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels",
abstract = "The nuclear receptor peroxisome-proliferation-activated receptor gamma (PPARγ), a transcriptional master regulator of glucose and lipid metabolism, inhibits the growth of several common cancers, including lung cancer. In this study, we show that the mechanism by which activation of PPARγ inhibits proliferation of lung cancer cells is based on metabolic changes. We found that treatment with the PPARγ agonist pioglitazone triggers a metabolic switch that inhibits pyruvate oxidation and reduces glutathione levels. These PPARγ-induced metabolic changes result in a marked increase of reactive oxygen species (ROS) levels that lead to rapid hypophosphorylation of retinoblastoma protein (RB) and cell-cycle arrest. The antiproliferative effect of PPARγ activation can be prevented by suppressing pyruvate dehydrogenase kinase 4 (PDK4) or β-oxidation of fatty acids in vitro and in vivo. Our proposed mechanism also suggests that metabolic changes can rapidly and directly inhibit cell-cycle progression of cancer cells by altering ROS levels.",
author = "Nishi Srivastava and Kollipara, {Rahul K.} and Singh, {Dinesh K.} and Jessica Sudderth and Zeping Hu and Hien Nguyen and Shan Wang and Humphries, {Caroline G.} and Ryan Carstens and Huffman, {Kenneth E.} and Deberardinis, {Ralph J.} and Ralf Kittler",
year = "2014",
month = "10",
day = "7",
doi = "10.1016/j.cmet.2014.08.003",
language = "English (US)",
volume = "20",
pages = "650--661",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels

AU - Srivastava, Nishi

AU - Kollipara, Rahul K.

AU - Singh, Dinesh K.

AU - Sudderth, Jessica

AU - Hu, Zeping

AU - Nguyen, Hien

AU - Wang, Shan

AU - Humphries, Caroline G.

AU - Carstens, Ryan

AU - Huffman, Kenneth E.

AU - Deberardinis, Ralph J.

AU - Kittler, Ralf

PY - 2014/10/7

Y1 - 2014/10/7

N2 - The nuclear receptor peroxisome-proliferation-activated receptor gamma (PPARγ), a transcriptional master regulator of glucose and lipid metabolism, inhibits the growth of several common cancers, including lung cancer. In this study, we show that the mechanism by which activation of PPARγ inhibits proliferation of lung cancer cells is based on metabolic changes. We found that treatment with the PPARγ agonist pioglitazone triggers a metabolic switch that inhibits pyruvate oxidation and reduces glutathione levels. These PPARγ-induced metabolic changes result in a marked increase of reactive oxygen species (ROS) levels that lead to rapid hypophosphorylation of retinoblastoma protein (RB) and cell-cycle arrest. The antiproliferative effect of PPARγ activation can be prevented by suppressing pyruvate dehydrogenase kinase 4 (PDK4) or β-oxidation of fatty acids in vitro and in vivo. Our proposed mechanism also suggests that metabolic changes can rapidly and directly inhibit cell-cycle progression of cancer cells by altering ROS levels.

AB - The nuclear receptor peroxisome-proliferation-activated receptor gamma (PPARγ), a transcriptional master regulator of glucose and lipid metabolism, inhibits the growth of several common cancers, including lung cancer. In this study, we show that the mechanism by which activation of PPARγ inhibits proliferation of lung cancer cells is based on metabolic changes. We found that treatment with the PPARγ agonist pioglitazone triggers a metabolic switch that inhibits pyruvate oxidation and reduces glutathione levels. These PPARγ-induced metabolic changes result in a marked increase of reactive oxygen species (ROS) levels that lead to rapid hypophosphorylation of retinoblastoma protein (RB) and cell-cycle arrest. The antiproliferative effect of PPARγ activation can be prevented by suppressing pyruvate dehydrogenase kinase 4 (PDK4) or β-oxidation of fatty acids in vitro and in vivo. Our proposed mechanism also suggests that metabolic changes can rapidly and directly inhibit cell-cycle progression of cancer cells by altering ROS levels.

UR - http://www.scopus.com/inward/record.url?scp=84907977011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907977011&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2014.08.003

DO - 10.1016/j.cmet.2014.08.003

M3 - Article

VL - 20

SP - 650

EP - 661

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 4

ER -